首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

2016440

感染疾病物市場報告：按類型、給藥途徑、分銷管道和地區分類（2026-2034 年）

Anti-infectives Market Report by Type, Route of Administration (Topical, Oral, Intravenous, and Others), Distribution Channel, and Region 2026-2034

出版日期: 2026年04月01日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2025年全球感染疾病物市場規模達1,429億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到1,829億美元，2026年至2034年的複合年成長率為2.70%。

感染疾病物是指透過抑制病原體擴散或直接殺死病原體來對抗感染疾病的藥物。這些藥物包括抗生素、抗病毒藥、抗真菌藥物、抗瘧疾藥和抗寄生蟲藥。它們通常以口服、注射或局部用藥的方式給藥。抗感染藥物廣泛用於治療肺炎和結核病等輕度感染疾病。此外，在剖腹產和人工關節重建等常規手術中，由於有較高的嚴重感染疾病風險，也會使用感染疾病物。

抗感染藥物市場趨勢：

全球感染疾病物市場的主要驅動力是全球感染疾病的不斷上升。感染疾病物用於治療由病毒、細菌、寄生蟲和真菌引起的感染疾病。此外，採用不同策略開發的新型藥物，例如天然產物、群體感應抑制劑、生物膜破壞劑、鎵基藥物、環糊精抑制劑和光催化抗菌劑，正在推動市場成長。同時，藥物發現流程的最新創新，例如幹細胞和晶片器官（OOC）技術，用於增強藥物測試流程，也為市場帶來了良好的前景。此外，由於新冠肺炎疫情以及由此導致的麴菌症、侵襲性念珠菌症和白黴菌症等感染疾病的增加，人們對相關產品的使用量增加，也推動了市場成長。此外，監管機構核准的新感染疾病物數量不斷增加也是推動市場成長的因素之一。此外，政府扶持措施的實施、對創新藥物研發投入的增加、意識提升對感染疾病認知的提高以及醫療基礎設施的快速發展，預計將在未來幾年推動市場成長。

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

ANTI-INFECTIVES MARKET TRENDS:

The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

KEY MARKET SEGMENTATION:

Breakup by Type:

Antibacterial
Antifungal
Antiviral

Breakup by Route of Administration:

Topical
Oral
Intravenous (IV)
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Speciality Pharmacies
Online Stores
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global anti-infectives market with detailed profiles of all major companies, including:

Abbott Laboratories
Cipla Health
F. Hoffmann-La Roche Ltd
Fresenius SE & Co. KGaA
Glenmark Pharmaceuticals Limited
GSK plc
Lupin Limited
Mankind Pharma Limited
Sandoz Inc.
Sun Pharmaceutical Industries Ltd.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global anti-infectives market in 2025?

2. What is the expected growth rate of the global anti-infectives market during 2026-2034?

3. What are the key factors driving the global anti-infectives market?

4. What has been the impact of COVID-19 on the global anti-infectives market?

5. What is the breakup of the global anti-infectives market based on the type?

6. What is the breakup of the global anti-infectives market based on the route of administration?

7. What is the breakup of the global anti-infectives market based on distribution channel?

8. What are the key regions in the global anti-infectives market?

9. Who are the key players/companies in the global anti-infectives market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Anti-infectives Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Antibacterial
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Antifungal
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Antiviral
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

7.1 Topical
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Oral
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Intravenous (IV)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Speciality Pharmacies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Online Stores
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Cipla Health
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 F. Hoffmann-La Roche Ltd
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Fresenius SE & Co. KGaA
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Glenmark Pharmaceuticals Limited
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 GSK plc
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Lupin Limited
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Mankind Pharma Limited
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Sandoz Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Sun Pharmaceutical Industries Ltd.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
Figure 2: Global: Anti-infectives Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2025
Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2025
Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2025
Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2025
Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million USD), 2020 & 2025
Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million USD), 2020 & 2025
Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million USD), 2020 & 2025
Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million USD), 2020 & 2025
Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million USD), 2020 & 2025
Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million USD), 2020 & 2025
Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million USD), 2020 & 2025
Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million USD), 2020 & 2025
Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 32: North America: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 34: United States: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 36: Canada: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 40: China: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 42: Japan: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 44: India: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 48: Australia: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 52: Others: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 54: Europe: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 56: Germany: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 58: France: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 62: Italy: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 64: Spain: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 66: Russia: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 68: Others: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 76: Others: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million USD), 2020 & 2025
Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2025
Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: Global: Anti-infectives Industry: SWOT Analysis
Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million USD), 2026-2034
Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Anti-infectives Market: Competitive Structure
Table 7: Global: Anti-infectives Market: Key Players

02-2729-4219

+886-2-2729-4219